mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2025
Joanna Smith - June 3, 2025

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2025

We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...

Mewburn Ellis: top tier firm Legal 500 2025
Joanna Smith - October 2, 2024

Mewburn Ellis: top tier firm Legal 500 2025

We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024
Joanna Smith - June 10, 2024

Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024

We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...

Validating European patents outside Europe - the Validation State system
Jacqueline Murphy - November 8, 2023

Validating European patents outside Europe - the Validation State system

We are pleased to launch our latest report Validating European patents outside Europe - the ...

Mewburn Ellis: top tier firm Legal 500 2024
Joanna Smith - October 5, 2023

Mewburn Ellis: top tier firm Legal 500 2024

We are extremely proud to once again be ranked tier one for our patent and trade mark practices in ...

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023
Joanna Smith - July 4, 2023

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

Mewburn Ellis: top tier firm Legal 500 2023
Jacqueline Murphy - October 14, 2022

Mewburn Ellis: top tier firm Legal 500 2023

We are extremely proud to be ranked tier one for our patent and trade mark practices in the 2023 ...

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022
Jacqueline Murphy - July 4, 2022

Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

Pulse of Fintech H1 ’21 – investments in fintech are growing and diversifying
Robert Worboys - November 16, 2021

Pulse of Fintech H1 ’21 – investments in fintech are growing and diversifying

KPMG have recently published their biannual report ‘Pulse of Fintech’, which provides a detailed ...

New Green IP Report launched
Jacqueline Murphy - October 26, 2021

New Green IP Report launched

To coincide with the launch of COP26 we have released a new report into Green IP. Our report ...

Mewburn Ellis: top tier firm Legal 500 2022
Jacqueline Murphy - September 30, 2021

Mewburn Ellis: top tier firm Legal 500 2022

Mewburn Ellis is proud to be ranked top tier for our patent and trade mark practices in the 2022 ...

Software Inventions: UKIPO and EPO approaches to patent eligibility Special Report
James Leach - September 15, 2021

Software Inventions: UKIPO and EPO approaches to patent eligibility Special Report

Our new Special Report, Software Inventions: UKIPO and EPO approaches to patent eligibility, has ...

New Innovation Strategy for the UK
Graeme Moore - August 24, 2021

New Innovation Strategy for the UK

Last month the UK government launched a new Innovation Strategy, which seems to blend a long-term ...

IAM Patent 1000: The World’s Leading Patent Professionals 2021
Jacqueline Murphy - July 2, 2021

IAM Patent 1000: The World’s Leading Patent Professionals 2021

We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...

EPO Opposition Trends in Engineering, Electronics and Software Special Report
Helen Bower - May 10, 2021

EPO Opposition Trends in Engineering, Electronics and Software Special Report

In autumn 2020, we analysed more than 8000 opposition cases filed at the European Patent Office ...

Mewburn Ellis: top tier firm Legal 500 2021
Jacqueline Murphy - October 1, 2020

Mewburn Ellis: top tier firm Legal 500 2021

We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...

The journey of rLoop - a new technology innovation network disrupting the world of transport and IP
Graeme Moore - May 29, 2019

The journey of rLoop - a new technology innovation network disrupting the world of transport and IP

As a child growing up in Blackburn, near Manchester, UK, Ilyas Vali dreamed of owning a dog. He ...

Blockchain: the next patent boom
Graeme Moore - December 13, 2018

Blockchain: the next patent boom

Emma Graham and Graeme Moore attended the EPO’s “Patenting Blockchain” conference in The Hague – ...

Patenting board games and puzzles
Graeme Moore - October 19, 2018

Patenting board games and puzzles

Quite a lot of people think of new games and puzzles, and wonder whether patenting would help them ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy